Results 1 to 10 of about 549,826 (262)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Background/Aims Real-world studies assessing the effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) plus ribavirin (RBV) for Child-Pugh B/C hepatitis C virus (HCV)-related cirrhosis are limited.
Chen-Hua Liu   +28 more
doaj   +1 more source

The Circulating miRNA Profile of Chronic Hepatitis D and B Patients Is Comparable but Differs from That of Individuals with HBeAg-Negative HBV Infection

open access: yesViruses, 2023
miRNAs circulating in whole serum and HBsAg-particles are differentially expressed in chronic hepatitis B (CHB) and HBeAg-negative-HBV infection (ENI); their profiles are unknown in chronic hepatitis D (CHD).
Daniela Cavallone   +9 more
doaj   +1 more source

The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?

open access: yesArchives of Public Health, 2021
Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi   +10 more
doaj   +1 more source

Association between risk factors, basal viral load, virus genotype and the degree of liver fibrosis with the response to the therapy in patients with chronic hepatitis C virus infection [PDF]

open access: yesVojnosanitetski Pregled, 2015
Background/Aim. Hepatitis C is an important sociomedical problem worldwide due to frequent progression to chronic disease, occurrence of liver cirrhosis and hepatocellular carcinoma.
Vuković Vuk R.   +6 more
doaj   +1 more source

Stigmatization and discrimination of patients with chronic hepatitis C [PDF]

open access: yesVojnosanitetski Pregled, 2016
Background/Aim. Chronic hepatitis C (CHC) is often associated with injectable drug users and human immunodeficiency virus coinfection for which there is stigmatization in society.
Kostić Marina   +2 more
doaj   +1 more source

Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine

open access: yesViruses, 2022
The currently available antiviral treatments (Peg-Interferon-α and Nucleos(t)ide Analogues, NA) for chronic hepatitis B (CHB) achieve a functional cure (serum HBsAg and HDV-DNA clearance) of HBV infection in a limited number of patients.
Piero Colombatto   +3 more
doaj   +1 more source

OBESITY AND DYSLIPIDEMIA IN CHILDREN WITH CHRONIC HEPATITIS [PDF]

open access: yesRomanian Journal of Pediatrics, 2016
Chronic hepatitis association with various types of dyslipidemia is a reality not only for the obese pediatric patient, in which we expect to find hypercholesterolemia and / or hypertriglyceridemias, but also for normal weight children with hepatitis ...
Alice N. Azoicai   +7 more
doaj   +1 more source

Viruses and miRNAs: More Friends than Foes

open access: yesFrontiers in Microbiology, 2017
There is evidence that eukaryotic miRNAs (hereafter called host miRNAs) play a role in the replication and propagation of viruses. Expression or targeting of host miRNAs can be involved in cellular antiviral responses.
Patrice Bruscella   +5 more
doaj   +1 more source

Different profiles of neurocognitive impairment in patients with hepatitis B and C virus infections

open access: yesScientific Reports, 2022
The direct impact of chronic hepatitis B and hepatitis C on neurocognition remains elusive due to the frequent comorbidities, and the domains of the neurocognitive functions affected have rarely been investigated comprehensively.
Chun-Hsiang Tan   +9 more
doaj   +1 more source

ETIOLOGICAL CHARACTERISTICS OF CHRONIC VIRAL HEPATITIS IN THE KHOREZM REGION OF UZBEKISTAN

open access: yesБайкальский медицинский журнал, 2023
A study of the etiological structure of chronic viral hepatitis is presented, taking into account the assessment of the stage of the pathological process and the genotypic affiliation of pathogens in the Khorezm region of the Republic of Uzbekistan.
Shavkat R. Yusupov   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy